Skip to content

Multiverse Ventures

A venture studio building the future of biotech, medicine, and life sciences.

Floating DNA helix

Our Investment Focus

Laboratory research with petri dishes and scientific equipment

Biotechnology Innovation

Advancing breakthrough therapies and diagnostic tools. We work hands-on with companies developing novel biological solutions, from gene therapy to synthetic biology platforms that reshape treatment paradigms.
Medical technology and healthcare equipment

Medical Technology

Engineering the next generation of healthcare devices. From AI-powered diagnostics to minimally invasive surgical robotics, we provide operational support and strategic guidance for technologies that improve patient outcomes.
DNA sequencing and genomic research

Life Sciences Research

Accelerating drug discovery and development. We advise and support platforms that leverage computational biology, high-throughput screening, and precision medicine to bring life-saving treatments to market faster.
Digital health data visualization and analytics

Digital Health & Data

Transforming healthcare through data and connectivity. We help build digital therapeutics, remote patient monitoring, and clinical data platforms that make healthcare more accessible and personalized.

Portfolio Companies

Our Team

Paulomi Modi

Paulomi Modi

General Partner

Vincent Pham

Vincent Pham

General Partner

Portfolio Highlights

Gene therapy research with pipettes and samples
Biotechnology

Revolutionary
Gene Therapy Platform

BioGenix developed a next-generation AAV vector platform that delivers 10x higher transduction efficiency.

With our support, they secured FDA Fast Track designation and are now in Phase 2 clinical trials for rare genetic disorders.
Learn More
Medical imaging and AI diagnostics
Medical Technology

AI-Powered
Diagnostic Platform

NeuralPath's machine learning platform analyzes medical imaging with 95% accuracy, reducing diagnosis time from days to minutes.

Now deployed in 50+ hospitals, improving patient outcomes and reducing healthcare costs.
View Case Study
Genomic sequencing and data analysis
Life Sciences

Precision Medicine
Data Platform

GenomicAI built a comprehensive genomic data platform that integrates multi-omic data for personalized treatment recommendations.

Partnered with 3 major pharmaceutical companies to accelerate drug discovery programs.
Explore Platform

What Our Founders Say

Multiverse Ventures didn't just provide capital—they brought deep scientific expertise and strategic connections that accelerated our path to clinical trials.

@Dr. Sarah Chen, BioGenix

The team understood our vision from day one. Their network opened doors with hospital systems and regulatory advisors that would have taken us years to build.

@Michael Torres, NeuralPath

Working with Multiverse has been transformative. They've been hands-on partners, helping us navigate everything from FDA pathways to strategic partnerships with pharma.

@Dr. Lisa Anderson, CellForge

Beyond funding, they provided operational support and introduced us to world-class scientific advisors who shaped our platform.

@James Park, GenomicAI

Their deep understanding of both the science and business of biotech has been invaluable. They're true partners in building breakthrough therapies.

@Dr. Rachel Kim, PrecisionRx

Multiverse Ventures brought credibility and connections that helped us recruit top talent and secure follow-on funding from major institutional investors.

@David Singh, VitaSense

They understood the unique challenges of medical device development and connected us with key opinion leaders who became clinical trial partners.

@Dr. Emily Brown, MedFlow

The operational playbook they shared accelerated our go-to-market by 12 months. Their portfolio network is incredibly collaborative.

@Alex Martinez, SynthBio Labs

From term sheet to Series A, they've been exceptional partners—deeply engaged, scientifically rigorous, and always available.

@Dr. Kevin Liu, HealthConnect

They combine venture expertise with genuine scientific depth. Every interaction adds value beyond the capital.

@Jennifer Walsh, BioMetrics

Frequently Asked Questions

What types of companies does Multiverse Ventures work with?
We work with early-stage biotech, medical technology, and life sciences companies developing breakthrough therapies, diagnostic tools, medical devices, and data platforms. We look for innovative science, strong founding teams, and clear paths to clinical validation or market adoption.
What stage of companies do you typically support?
We work primarily with Seed and Series A stage companies, though we occasionally engage with pre-seed stage teams with exceptional potential. We prefer companies with preliminary data or proof-of-concept that need operational expertise to scale.
How does the venture studio model work?
We provide hands-on operational support including strategic guidance, regulatory expertise, clinical trial design, talent recruitment, and introductions to our network of scientific advisors, hospital systems, pharmaceutical partners, and investors. We help you build and scale without taking capital deployment.
Do you provide capital investment?
Currently, we focus on operational support, strategic advising, and making key introductions rather than direct capital investment. We help connect portfolio companies with our network of investors and funding sources.
How can I apply for funding?
Submit your pitch deck and executive summary through our contact form. Our team reviews all submissions within two weeks. If there's a fit, we'll schedule an initial meeting to discuss your science, team, and vision.